BIO to Testify at House Hearing on User Fee Reauthorization
- Contact: Peper Long
Dan Eramian
(202) 962-9200
Related Content
- BIO To Testify Before House Committees on Project BioShield
- BIO Calls for Federal Funding Improvements for Biotech Research and Development
- Biotechnology Industry Spokespeople Available to Comment on Follow-On Biologics
- BIOTECHNOLOGY INDUSTRY REPRESENTATIVE TO TESTIFY ON MEDICARE PRESCRIPTION DRUG BENEFIT
WASHINGTON, D.C. (March 5, 2002) - Mary Pendergast, executive vice president for government affairs at Elan Pharmaceuticals, will testify tomorrow on behalf of the Biotechnology Industry Organization (BIO) on the reauthorization of the Prescription Drug User Fee Act (PDUFA).
| What: | House Committee on Energy and Commerce Subcommittee on Health - hearing on the reauthorization of PDUFA |
| When: | Wednesday, March 6, 2002, 10 a.m. |
| Where: | 2322 Rayburn House Office Building |
| Who: | Mary Pendergast, executive vice president for government affairs Elan Pharmaceuticals Lester Crawford, DVM, PhD, deputy commissioner Food and Drug Administration Timothy Franson, MD, vice president, clinical research & regulatory affairs, U.S. Eli Lilly Research Laboratories Alastair Wood, MD, assistant vice chancellor for research Vanderbilt University School of Medicine |
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.
# # #
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.
